Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2045884 | 0.94 | MEN1 (0.30) | MEN1GAAKMT2A | |
| SCHEMBL13238426 | 0.73 | MAPT (0.39) | MEN1KMT2ANPC1ALDH1A1MAPT | |
| SCHEMBL31258313 | 0.69 | KDM4E (0.33) | NPC1 | |
| SCHEMBL28059372 | 0.68 | TACR1 (0.33) | MEN1KMT2ANPC1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL3670743 | 0.67 | CRHR1 (0.33) | MEN1KMT2ANPC1ALDH1A1MAPT | |
| Pyridine SCHEMBL920961 | 0.65 | CRHR1 (0.33) | NPC1ALDH1A1MAPTRAB9A | |
| Hydrochloric Acid SCHEMBL31258314 | 0.65 | — | — | |
| SCHEMBL2882672 | 0.65 | ALDH1A1 (0.33) | MEN1KMT2ANPC1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL3670747 | 0.64 | ALDH1A1 (0.32) | MEN1KMT2ANPC1ALDH1A1MAPT | |
| SCHEMBL23216998 | 0.63 | CRHR1 (0.30) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125499-A1 | CATALYST LIQUID AND POLYMERIZABLE COMPOSITION | RIMTEC CORPORATION (JP) | 2026-05-07 | — | — | US | disclosed |
| EP-4606837-A1 | POLYMERIZABLE COMPOSITION AND NORBORNENE RESIN | RIMTEC Corporation (JP) | 2025-08-27 | — | — | EP | disclosed |
| EP-2653501-B1 | CROSSLINKABLE RESIN MOLDED BODY, AND LAMINATE | ZEON CORP (JP) | 2019-05-22 | — | — | EP | disclosed |
| EP-2620483-B1 | ADHESIVE FILM FOR ORGANIC ELECTROLYTE ACCUMULATOR DEVICES | ZEON CORP (JP) | 2016-02-10 | — | — | EP | disclosed |
| US-8759463-B2 | Cross-linkable resin shaped article, cross-linked resin shaped article and laminate | ZEON CORPORATION (JP) | 2014-06-24 | — | — | US | disclosed |
| EP-2653501-A1 | CROSSLINKABLE RESIN MOLDED BODY, CROSSLINKED RESIN MOLDED BODY, AND LAMINATE | Zeon Corporation (JP) | 2013-10-23 | — | — | EP | disclosed |
| US-20130267672-A1 | CROSS-LINKABLE RESIN SHAPED ARTICLE, CROSS-LINKED RESIN SHAPED ARTICLE AND LAMINATE | ZEON CORPORATION (JP) | 2013-10-10 | — | — | US | disclosed |
| EP-2620483-A1 | ADHESIVE FILM FOR ORGANIC ELECTROLYTE ACCUMULATOR DEVICES | Zeon Corporation (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-20130183519-A1 | ADHESIVE FILM FOR ORGANIC ELECTROLYTE-TYPE ENERGY STORAGE DEVICE | ZEON CORPORATION (JP) | 2013-07-18 | — | — | US | disclosed |
| US-7964685-B2 | Polymerizable composition | ZEON CORPORATION (JP) | 2011-06-21 | — | — | US | disclosed |
| US-20100144924-A1 | POLYMERIZABLE COMPOSITION | ZEON CORPORATION (JP) | 2010-06-10 | — | — | US | disclosed |
| EP-2098550-A1 | POLYMERIZABLE COMPOSITION | ZEON CORPORATION (JP) | 2009-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125499-A1 | CATALYST LIQUID AND POLYMERIZABLE COMPOSITION | TCP1, ROS1, PEAK1 | MEN1 1052/4885GAA 4110/4885KMT2A 3300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.